Kodiak Sciences Inc. (KOD) vs Palvella Therapeutics, Inc. (PVLA)

Kodiak Sciences Inc. and Palvella Therapeutics, Inc. are both Biotechnology companies. Kodiak Sciences Inc. and Palvella Therapeutics, Inc. are of similar size ($2.1B and $2.1B). Across the 9 metrics below, Palvella Therapeutics, Inc. leads on 8 and Kodiak Sciences Inc. on 1.

Valuation

Metric KOD PVLA Biotechnology median
P/E n/m n/m 7.88
P/S n/m 48.46 11.47
P/B 33.16 9.15 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 42.37 10.73
Earnings yield (12.95%) (3.50%) (28.84%)
Free cash flow yield (7.89%) (1.62%) (23.03%)

Profitability

Metric KOD PVLA Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (368.37%) (46.63%) (57.72%)
Return on assets (94.25%) (37.70%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KOD PVLA Biotechnology median
Revenue growth (TTM) — 142.89% 5.64%
EPS growth (last fiscal year) (28.96%) 52.62% —
Revenue growth, 5-year CAGR — 8.03% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KOD PVLA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.49 21.18 4.73
Net debt to EBITDA 1.01 1.50 0.96

Dividend

Metric KOD PVLA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KOD PVLA Biotechnology median
Market cap 2.09b 2.10b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack